The role of PCI and CABG in the management of coronary artery disease in patients with diabetes (Q35087384)

6 August 2017

1 reference

title

The role of PCI and CABG in the management of coronary artery disease in patients with diabetes (English)

1 reference

coronary artery bypass surgery

6 August 2017

main subject

0 references

coronary artery disease

1 reference

3

Hartzell V Schaff

1 reference

6 August 2017

Robert L Frye

1

1 reference

6 August 2017

Malcolm R Bell

series ordinal

2

1 reference

6 August 2017

Richard Holubkov

series ordinal

4

1 reference

6 August 2017

Katherine M Detre

series ordinal

5

1 reference

6 August 2017

publication date

1 February 2002

1 reference

6 August 2017

published in

Current diabetes report

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

16-20

1 reference

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0052-Z

Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0052-Z

Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0052-Z

Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0052-Z

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0052-Z

Multivessel balloon angioplasty should be abandoned in diabetic patients!

21 January 2018

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators

1 reference

12 December 2020

Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty

1 reference

12 December 2020

Aspirin therapy in diabetes. American Diabetes Association

1 reference

12 December 2020

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

1 reference

12 December 2020

Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery

1 reference

12 December 2020

A new look at the heart in diabetes mellitus: from ailing to failing

1 reference

12 December 2020

Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group

1 reference

12 December 2020

von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI)

1 reference

12 December 2020

Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials

1 reference

12 December 2020

Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status

1 reference

12 December 2020

Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting

1 reference

12 December 2020

The spread of the obesity epidemic in the United States, 1991-1998

1 reference

12 December 2020

The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients

1 reference

12 December 2020

Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

12 December 2020

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy

1 reference

12 December 2020

The Effect of Previous Coronary-Artery Bypass Surgery on the Prognosis of Patients with Diabetes Who Have Acute Myocardial Infarction

1 reference

12 December 2020

Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study

1 reference

12 December 2020

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

12 December 2020

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease

1 reference

12 December 2020

Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association

1 reference

12 December 2020

Diabetes trends in the U.S.: 1990-1998.

1 reference

12 December 2020

Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode

1 reference

12 December 2020

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

1 reference

12 December 2020

Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations

1 reference

12 December 2020

10.1007/S11892-002-0052-Z

Identifiers

DOI

1 reference

6 August 2017

1 reference